Your browser doesn't support javascript.
loading
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.
Abdallah, Mahmoud S; Mosalam, Esraa M; Hassan, Ahmed; Ramadan, Ahmed N; Omara-Reda, Hend; Zidan, Abdel-Aziz A; Samman, Waad A; El-Berri, Eman I.
Afiliação
  • Abdallah MS; Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.
  • Mosalam EM; Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebeen El-Kom, Egypt.
  • Hassan A; Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt.
  • Ramadan AN; Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt.
  • Omara-Reda H; Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt.
  • Zidan AA; Zoology Department, Faculty of Science, Damanhour University, Damanhour, Egypt.
  • Samman WA; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Saudi Arabia.
  • El-Berri EI; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
CNS Neurosci Ther ; 29(1): 354-364, 2023 01.
Article em En | MEDLINE | ID: mdl-36341700

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pentoxifilina / Esquizofrenia / Antipsicóticos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pentoxifilina / Esquizofrenia / Antipsicóticos Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito